We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Patents and Exclusivity
Drug Safety Communications
The Accelerated Approval Program
Communicating Drug Safety Messages
The Electronic Orange Book
Alyson Saben on the Eyes, Ears, and Muscle Behind FDA's Efforts to Protect Public Health.
John Jenkins on Changes in the Way New Drugs are Evaluated.
Dr. Dianne Murphy on Effective and Proper Uses of Medicines and Devices in Children
Tim Coté on Orphan Drugs and the Fight Against Rare Diseases
Drug Name Review
Managing Drug Shortages
Communicating Benefit and Risk Information
New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)
Emerging Science in the Personalized Pursuit of Remission in Ulcerative Colitis Patients
You need to be logged in to save this episode to a playlist.
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education